Companies: 10,795·Total market cap: $144.5T
Repligen Corporation

Repligen Corporation

RGENNASDAQHealthcare● Active
$125.61
+$3.30(+2.70%)
Market Cap$7.1B
P/E Ratio
52W High$175.77
52W Low$100.99

Repligen Corporation(RGEN)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · RGEN · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.74B$0.63B$0.63B$0.80B$0.67B
Cost of Revenue$0.39B$0.36B$0.35B$0.35B$0.28B
Gross Profit$0.35B$0.27B$0.28B$0.46B$0.39B
Gross Margin %(computed)47.09%43.29%44.03%56.85%58.35%
Operating Expenses
R&D Expenses$0.05B$0.04B$0.04B$0.04B$0.03B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$0.29B$0.31B$0.23B$0.23B$0.22B
Operating Income$0.06B($0.04B)$0.05B$0.22B$0.17B
Operating Margin %(computed)8.07%-5.53%7.54%28.03%24.94%
Interest Income$0.03B$0.00B$0.00B$0.01B$0.00B
Interest Expense$0.02B$0.02B$0.01B$0.00B$0.01B
Income Before Tax$0.06B($0.03B)$0.06B$0.22B$0.15B
Income Tax Expense$0.01B($0.00B)$0.02B$0.03B$0.03B
Net Income$0.05B($0.03B)$0.04B$0.19B$0.13B
Net Margin %(computed)6.62%-4.02%5.63%23.20%19.13%
Per Share & EBITDA
EPS (Basic)$0.87$-0.46$0.64$3.35$2.33
Wtd Avg Shares0.06B0.06B0.06B0.06B0.06B
EBITDA$0.16B$0.08B$0.15B$0.28B$0.20B
EBITDA Margin %(computed)22.26%12.65%22.98%34.60%30.31%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Repligen Corporation

关于Repligen Corporation(RGEN)损益表

Repligen Corporation(RGEN)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,RGEN实现营收$0.74B,毛利润$0.35B(毛利率47.09%),净利润$0.05B(净利率6.62%)。

常见问题

RGEN · 4 问

Repligen Corporation(RGEN)2025财年营收为$0.74B,同比up16.4%。

RGEN revenueRGEN salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08